Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00810784
Recruitment Status : Completed
First Posted : December 18, 2008
Last Update Posted : December 18, 2008
Information provided by:
University of Utah

Brief Summary:
VTE prophylaxis is not as routinely employed in medically ill patients as compared to surgical patients. This retrospective chart review project will evaluate the effectiveness of VTE prophylaxis in medically ill patients at the University of Utah Hospitals and Clinics compared to current literature. The study will ultimately serve as a quality improvement project to help improve patient care.

Condition or disease Intervention/treatment
Venous Thromboembolism Behavioral: Education

Study Type : Observational
Actual Enrollment : 121 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
Study Start Date : March 2005
Actual Primary Completion Date : March 2007
Actual Study Completion Date : March 2007

Group/Cohort Intervention/treatment
Patients cared for before our intervention.
Patients cared for after our intervention.
Behavioral: Education
(1) a risk-assessment tool completed at the time of a hospital admission, (2) structured educational sessions on VTE prevention, and (3) audit-feedback where institutional data was reviewed during the educational sessions. These sessions were given once to the clinical pharmacists and on three separate occasions to the medicine house officers.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Data was collected on consecutive patients ≥18 years with a hospital length of stay of >48 hours admitted to the cardiology, pulmonary, or general medical services. Admission dates were a sample of two different two-week blocks (January 1-14, 2006 and April 1-14, 2006). These blocks were chosen to be consistent with dates of analysis in the pre-intervention cohort. Patients receiving therapeutic anticoagulation were excluded.

Inclusion Criteria:

  • Hospitalized at the University of Utah on one our medical services.

Exclusion Criteria:

  • Patients received therapeutic anticoagulation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00810784

United States, Utah
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132
Sponsors and Collaborators
University of Utah
Principal Investigator: Matthew Rondina, M.D. University of Utah

Responsible Party: Robert Pendleton, M.D., Associate Professor, University of Utah, University of Utah Identifier: NCT00810784     History of Changes
Other Study ID Numbers: UUHSC-IRB-00018164
First Posted: December 18, 2008    Key Record Dates
Last Update Posted: December 18, 2008
Last Verified: December 2008

Keywords provided by University of Utah:
Venous Thromboembolism
Quality Improvement
Compliance with VTE prophylaxis

Additional relevant MeSH terms:
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases